跳至主要内容
临床试验/DRKS00003394
DRKS00003394已完成未知

Prospective randomized study to comparing an extended pelvic lymphadenectomy with a limited in the surgical treatment of bladder cancer - LEA - AB 25/02 - LEA - AB 25/02

Klinikum rechts der Isar der TU München0 个研究点目标入组 459 人开始时间: 2012年1月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
459

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Histologically, muscle-invasive bladder cancer, locally completely resectable(T2 - T4a, Nx)
  • - Written consent of the patient
  • - Patient compliance and geographic proximity to allow adequate follow-up

排除标准

  • - Histologically or by imaging diagnostics proven organ metastases
  • - Radiographic evidence of enlarged lymph nodes (> 1 cm) above the aortic bifurcation in conjunction with pelvic lymph node metastases
  • - Radiographic or other evidence of T4b-tumor (infiltration of the pelvic wall or other organ systems)
  • - Prior neoadjuvant chemotherapy of bladder cancer
  • - Prior previous pelvic lymphadenectomy
  • - Prior radiotherapy to the pelvis
  • - internal medical or anesthetic risk factors that require a short operation time
  • - Palliative cystectomy (f.e. bulky-disease, infiltration of adjacent structures)
  • - Evidence of another tumor restricting life expectancy of the patient

研究者

发起方
Klinikum rechts der Isar der TU München

相似试验